Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kempf

Showing results (371-380 of 415) with videos related to

Pageof 42
Sort By:
Journal of Medicinal Chemistry|March 4, 1998
Discovery of ritonavir, a potent inhibitor of HIV protease with high oral bioavailability and clinical efficacyD J Kempf, H L Sham, K C Marsh, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2007
Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of unsymmetrical 1-hydroxy-4,4-dialkyl-3-oxo-3,4-dihydronaphthalene benzothiadiazine derivativesA Chris Krueger, Darold L Madigan, Brian E Green, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2019
Quinolone and Multidrug Resistance Predicts Failure of Antibiotic Prophylaxis of Spontaneous Bacterial PeritonitisMarcus M Mücke, Amelie Mayer, Johanna Kessel, et al.
AIDS (London, England)|April 15, 1999
Ritonavir and saquinavir combination therapy for the treatment of HIV infectionD W Cameron, A J Japour, Y Xu, et al.
Data in Brief|February 26, 2024
Multi-scale datasets for monitoring Mediterranean oak forests from optical remote sensing during the SENTHYMED/MEDOAK experiment in the north of Montpellier (France)K Adeline, J B Féret, H Clenet, et al.
Bioorganic & Medicinal Chemistry Letters|February 21, 2012
Novel hepatitis C virus replicon inhibitors: synthesis and structure-activity relationships of fused pyrimidine derivativesA Chris Krueger, Darold L Madigan, David W Beno, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 13, 2025
Metabolic Signatures of Acinetobacter baumannii and Klebsiella pneumoniae Infections in Acute-on-chronic Liver FailureCamilla Cadoli, Sania Arif, Wibke Ballhorn, et al.
Plos Pathogens|April 7, 2007
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremiaFrank Maldarelli, Sarah Palmer, Martin S King, et al.
The Pediatric Infectious Disease Journal|March 14, 2003
Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected childrenXavier Sáez-Llorens, Avyi Violari, Carl O Deetz, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Hepatitis C NS5B polymerase inhibitors: functional equivalents for the benzothiadiazine moietyDouglas K Hutchinson, Charles A Flentge, Pamela L Donner, et al.
Pageof 42

Showing results (371-380 of 415) with videos related to

Sort By:
Pageof 42
Journal of Medicinal Chemistry|March 4, 1998
Discovery of ritonavir, a potent inhibitor of HIV protease with high oral bioavailability and clinical efficacyD J Kempf, H L Sham, K C Marsh, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2007
Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of unsymmetrical 1-hydroxy-4,4-dialkyl-3-oxo-3,4-dihydronaphthalene benzothiadiazine derivativesA Chris Krueger, Darold L Madigan, Brian E Green, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2019
Quinolone and Multidrug Resistance Predicts Failure of Antibiotic Prophylaxis of Spontaneous Bacterial PeritonitisMarcus M Mücke, Amelie Mayer, Johanna Kessel, et al.
AIDS (London, England)|April 15, 1999
Ritonavir and saquinavir combination therapy for the treatment of HIV infectionD W Cameron, A J Japour, Y Xu, et al.
Data in Brief|February 26, 2024
Multi-scale datasets for monitoring Mediterranean oak forests from optical remote sensing during the SENTHYMED/MEDOAK experiment in the north of Montpellier (France)K Adeline, J B Féret, H Clenet, et al.
Bioorganic & Medicinal Chemistry Letters|February 21, 2012
Novel hepatitis C virus replicon inhibitors: synthesis and structure-activity relationships of fused pyrimidine derivativesA Chris Krueger, Darold L Madigan, David W Beno, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 13, 2025
Metabolic Signatures of Acinetobacter baumannii and Klebsiella pneumoniae Infections in Acute-on-chronic Liver FailureCamilla Cadoli, Sania Arif, Wibke Ballhorn, et al.
Plos Pathogens|April 7, 2007
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremiaFrank Maldarelli, Sarah Palmer, Martin S King, et al.
The Pediatric Infectious Disease Journal|March 14, 2003
Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected childrenXavier Sáez-Llorens, Avyi Violari, Carl O Deetz, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Hepatitis C NS5B polymerase inhibitors: functional equivalents for the benzothiadiazine moietyDouglas K Hutchinson, Charles A Flentge, Pamela L Donner, et al.
Pageof 42